Dashboard
Manage Tickers

CTMXCytomX Therapeutics, Inc.

Nasdaq cytomx.com


$ 1.25 $ 0.05 (4.17 %)    

Monday, 09-Sep-2024 15:59:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 1.25
$ 1.25 x 100
-- x --
-- - --
$ 1.04 - $ 5.85
741,832
na
97.65M
$ 1.05
$ 8.81
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-27-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-07-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 03-02-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 03-07-2016 12-31-2015 10-K
36 11-23-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cytomx-therapeutics-doses-first-patient-with-cx-801-in-phase-1-study-in-patients-with-solid-tumors
CytomX Therapeutics Doses First Patient Wi...
09/09/2024 12:06:05

hc-wainwright--co-reiterates-neutral-on-cytomx-therapeutics
HC Wainwright & Co. Reiterates Neutral on ...
08/22/2024 11:31:23

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral.

cytomx-therapeutics-files-250m-mixed-securities-shelf
Cytomx Therapeutics Files $250M Mixed Secu...
08/09/2024 20:11:34

- SEC Filing

cytomx-therapeutics-q2-2024-gaap-eps-008-beats-010-estimate-sales-25115m-beat-19995m-estimate
CytomX Therapeutics Q2 2024 GAAP EPS $(0.0...
08/08/2024 21:39:33

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $...

hc-wainwright--co-reiterates-neutral-on-cytomx-therapeutics
HC Wainwright & Co. Reiterates Neutral on ...
06/27/2024 10:33:09

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral.

cytomx-therapeutics-promotes-chris-ogden-to-chief-financial-officer-effective-june-15-2024
CytomX Therapeutics Promotes Chris Ogden T...
06/17/2024 20:16:39

ctmx---analyzing-cytomx-therapeuticss-short-interest
(CTMX) - Analyzing CytomX Therapeutics's S...
06/05/2024 17:00:25

piper-sandler-upgrades-cytomx-therapeutics-to-overweight-raises-price-target-to-35
Piper Sandler Upgrades CytomX Therapeutics...
05/28/2024 09:27:22

Piper Sandler analyst Joseph Catanzaro upgrades CytomX Therapeutics (NASDAQ:CTMX) from Neutral to Overweight and raises the ...

analysts-varied-perspectives-on-cytomxs-cx-904-cancer-study-safety-profile-but-caution-in-pancreatic-cancer
Analysts' Varied Perspectives On CytomX's ...
05/09/2024 18:59:21

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated pa...

gold-moves-higher-roblox-issues-weak-outlook
Gold Moves Higher; Roblox Issues Weak Outlook
05/09/2024 18:30:25

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

dow-jumps-over-150-points-us-foods-posts-upbeat-earnings
Dow Jumps Over 150 Points; US Foods Posts ...
05/09/2024 16:01:29

bmo-capital-maintains-market-perform-on-cytomx-therapeutics-raises-price-target-to-359
BMO Capital Maintains Market Perform on Cy...
05/09/2024 14:54:24

BMO Capital analyst Etzer Darout maintains CytomX Therapeutics (NASDAQ:CTMX) with a Market Perform and raises the price targ...

hc-wainwright--co-reiterates-neutral-on-cytomx-therapeutics
HC Wainwright & Co. Reiterates Neutral on ...
05/09/2024 14:08:49

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral.

wedbush-upgrades-cytomx-therapeutics-to-outperform-raises-price-target-to-8
Wedbush Upgrades CytomX Therapeutics to Ou...
05/09/2024 13:08:50

Wedbush analyst Robert Driscoll upgrades CytomX Therapeutics (NASDAQ:CTMX) from Neutral to Outperform and raises the price t...

why-applovin-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket
Why AppLovin Shares Are Trading Higher By ...
05/09/2024 12:13:28

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

cytomx-therapeutics-q1-2024-gaap-eps-017-beats-006-estimate-sales-41463m-beat-21434m-estimate
CytomX Therapeutics Q1 2024 GAAP EPS $0.17...
05/08/2024 21:01:06

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $...

cytomx-therapeutics-announces-initial-phase-1a-dose-escalation-data-for-monotherapy-cx-904-demonstrated-favorable-safety-profile-says-2-of-6-patients-confirmed-partial-response-and-all-6-patients-with-disease-control
CytomX Therapeutics Announces Initial Phas...
05/08/2024 20:50:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION